30.06 NICO - FENS Young investigator training program

Condividi su
Data dell'evento: 30/06/2014
FENS_SITO

The FENS Young investigator training program fellows
hosted at NICO and at the Department of Clinical and Biological Sciences present their research.

Monday, June 30 2014 -  from 12,00 to 13,30
Aula Seminari, NICO
André Luis Bombeiro
Institute of Biology, State University of Campinas (SP, Brazil)
"The involvement of immune system elements in experimental model of peripheral nerve regeneration"

Forostyak Serhij
Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic; Department of Neuroscience, 2nd Faculty of Medicine, Charles Univ in Prague
"Role of extracellular matrix and mesenchymal stromal cells in the course of amyotrophic lateral sclerosis"

Oliviera-Pinto Ana Virginia
Institute of Biomedical Sciences, Morphological Sciences Program, Department of Anatomy, Laboratory of Neuroplasticity, Federal University of Rio de Janeiro, Brazil
"Age and sex effects on absolute cellular composition in human cerebellum, hippocampal formation and olfactory bulb"

Download pdf

More information about the FENS Young Investigator Training Programme

Agenda

16 febbraio 2019

Torino - 10th International Meeting STEROIDS and NERVOUS SYSTEM

Since 2001, this meeting represented an important event for basic and clinical researchers working on this emerging scientific topic. We will address state-of-the-art approaches in the field of steroids and nervous system, including behavior, epigenetics, genomic and non-genomic actions, the vitamin D, neurodegenerative and psychiatric disorders, and the interference among endocrine disruptors and steroid signaling.

Ricerca

Identificato un nuovo bersaglio per contrastare la SMA

L’inibizione della proteina JNK rallenta la progressione della malattia che colpisce i motoneuroni ed è la prima causa genetica di morte nell’infanzia. Lo dimostra uno studio pubblicato su Frontiers in Molecular Neuroscience dal nostro gruppo di ricerca guidato da Alessandro Vercelli, in collaborazione con l’Istituto Mario Negri di Milano. Chiarire i meccanismi molecolari alla base della SMA può aprire la strada allo sviluppo di nuove terapie.

24 ottobre 2018